✨ Free AI Report
Patterson Companies, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Patterson Companies, Inc.
Company Research

Patterson Companies, Inc.: Business Overview, Financials & Competitive Analysis

Patterson Companies, Inc. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Established healthcare distributor with critical market position transitioning to private equity control to execute long-term restructuring away from quarterly pressures. Revenue declined from $6.56 billion in 2023 to $6.51 billion in 2024, and Q3 2025 earnings revealed declining sales and operating income in the dental segment with negative cash.

What is Patterson Companies, Inc.'s industry? Patterson Companies, Inc. (pattersoncompanies.com) operates in Healthcare and Life Sciences. AskCyborg classifies Patterson Companies, Inc. under Healthcare and Life Sciences in its company registry.

Patterson Companies distributes and sells dental and animal health products across the United States, the United Kingdom, and Canada through Dental and Animal Health business units. The company transitioned to private...

5/ 10Mixed

Cyborg Score thesis

Established healthcare distributor with critical market position transitioning to private equity control to execute long-term...

Read the full analyst-debate transcript →
Industry Healthcare and Life Sciences
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Patterson Companies, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Patterson Companies, Inc.

AskCyborg analysts argue the bull and bear cases for Patterson Companies, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Patterson Companies, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Patterson Companies, Inc. Overview

Pro stress-test →

Patterson Companies distributes and sells dental and animal health products across the United States, the United Kingdom, and Canada through Dental and Animal Health business units. The company transitioned to private ownership in April 2025 following acquisition by Patient Square Capital for approximately $4.1 billion announced in December 2024.

Strategic Profile

Pro stress-test →

The Dental unit offers consumable products including infection control, restorative materials, hand instruments, dental equipment, and practice management software, while the Animal Health unit provides veterinary supplies, pharmaceuticals, vaccines, diagnostics, and practice management software. Under private equity ownership, Patterson prioritizes long-term growth and digital transformation for new technological offerings to dental and veterinary practices.

Competitive Landscape

Pro stress-test →

Primary competitors in dental and healthcare distribution include Henry Schein, Cencora, and Cardinal Health, which occupy similar positions in specialty medical and dental supply distribution. Patterson differentiated through dual-market focus across dental and animal health, though competitive pressures in both segments have intensified in recent years.

Industry Context

Patterson Companies, Inc. operates in Healthcare and Life Sciences.

Key facts

Founded: 1877 · Headquarters: Saint Paul, US · Revenue: $6.51B (2024)

What the analysts stress-tested

The top findings that survived the multi-agent debate for Patterson Companies, Inc..

  • Acquisition closed on April 16, 2025, with delisting from NASDAQ on April 17, 2025, ending 40+ years of public trading history
  • Revenue declined 0.8% year-over-year in 2024 despite 1.5% growth reported in alternative sources, indicating market headwinds in dental and animal health segments
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2025Acquisition closed by Patient Square Capital; company delisted from NASDAQ and transitioned to private ownership
  • December 2024Definitive merger agreement announced with Patient Square Capital for $4.1 billion at $31.35 per share
  • +1 moreTrack every material event for Patterson Companies, Inc. as it happens. Explore monitoring →
Get alerted when Patterson Companies, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Henry ScheinDental and healthcare solutions distributor→CencoraHealthcare services and pharmaceutical distributor→Cardinal HealthMedical and pharmaceutical distribution→

Compare Patterson Companies, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Patterson Companies, Inc. operates in Healthcare and Life Sciences. See how the rest of the sector scores on the Cyborg framework.

Browse Healthcare and Life Sciences research →
NEW · MCP server

Ask your AI assistant about Patterson Companies, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Patterson Companies, Inc. and its top competitor on Cyborg Score”
“What did Patterson Companies, Inc. do this quarter?”
“Is Patterson Companies, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Patterson Companies, Inc. do?+
Patterson Companies distributes and sells dental and animal health products across the United States, the United Kingdom, and Canada through Dental and Animal Health business units. The company transitioned to private...
What is Patterson Companies, Inc.'s Cyborg Score?+
Patterson Companies, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Patterson Companies, Inc.'s main competitors?+
Named competitors include Henry Schein, Cencora, Cardinal Health. The full competitive landscape is in the AskCyborg report.
How can I get the full Patterson Companies, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Patterson Companies, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Patterson Companies, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Healthcare and Life Sciences research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Cencora, Inc.